Health In Tech, Inc. (NASDAQ:HIT) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 13, 2026.
At publication ·
Health In Tech, Inc. (NASDAQ:HIT) · proxy filed
At a glance
Health In Tech, Inc. (NASDAQ:HIT) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 13, 2026.
The Technology company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Health In Tech, Inc.'s stock currently trades at $0.68 with a market capitalization of $60.6M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing Health In Tech, Inc.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for Health In Tech, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HIT Stock Page
Browse all filings on our HIT SEC filings page.
Public companies like Health In Tech, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · HIT
$0.56
Down: -$0.01 · -2.26%
Live quote updated
Keep reading
